Background Population-based statistical probabilistic anatomical maps have been used to generate probabilistic volumes of interest for analyzing perfusion and metabolic brain imaging. We investigated the feasibility of automated analysis for dopamine transporter images using this technique and evaluated striatal binding potentials in Parkinson's disease and Wilson's disease. Materials and Methods We analyzed 2β-Carbomethoxy-3β-(4-123
Introduction
Quantifiability is a major advantage of nuclear medicine imaging, which yields images of great clinical value. Because small errors in regions of interest (ROIs) can result in large discrepancies, generating ROIs is very important for quantitative analysis. Such errors can occur with manual drawing of the ROI. Furthermore, ROI values can vary between the manual drawing and setting of the ROI.
Evolving computer technology has developed advanced image-matching and transformation techniques such as voxel-based comparison with statistical parametric mapping (SPM) and a population-based probabilistic brain atlas called a "statistical probabilistic anatomical map" (SPAM) [1] . The user can easily designate the volume of interest (VOI) with such a standardized brain map, minimizing interpersonal variation and maximizing the reproducibility with SPAM. These SPM and SPAM techniques have been applied to several kinds of brain imaging analysis including dopamine receptor imaging [2] [3] [4] [5] [6] .
Parkinson's disease (PD) and Wilson's disease (WD) are neurodegenerative disorders that primarily affect the striatal area of the midbrain. Therefore, dopamine transporter ligand images can be helpful for diagnosing PD and WD. 2β-Carbomethoxy-3β- (4- 123 I-iodophenyl)tropane ( 123 I-beta-CIT) is one of the radiopharmaceuticals for dopamine transporter imaging that is suitable for single-photon emission computed tomography (SPECT) [7] .
In this study, we investigated the feasibility of automatic analysis of dopamine transporter images using the SPAM technique and evaluated the striatal binding potential in patients with PD and WD.
Materials and Methods

Subjects
From 1996 to 2002, we retrospectively analyzed the 123 I-beta-CIT SPECT brain images of 26 people with PD, 9 people with WD, and 17 normal controls. The protocol was approved by the local institutional review board, and patient consent was not required because of the retrospective nature of the study. The mean age of the 26 participants with PD (15 women and 11 men) was 49.2±12.0 years. These participants with three or more classical PD symptom including resting tremor, postural instability, rigidity, and bradykinesia had been clinically diagnosed by a neurologist. The mean age of the nine participants with WD (3 women and 6 men) was 26.1± 11.9 years. Neurologists confirmed the diagnosis by an appropriate history of neurological impairment, low serum ceruloplasmin concentration, low serum copper concentration, increased urinary copper excretion, and Kayser-Fleischer rings. All participants had Parkinsonian symptoms and dystonia as neurological manifestations of WD. The average age of the 17 normal controls (12 women and 5 men) was 38.8±16.0 years. None of them had a history of neuropsychiatric disease or signs of neurological impairment, which was confirmed by neurologists.
To control for age-related changes in neurological status, we selected 11 age-matched normal controls for participants with PD (8 women and 3 men, mean age 49.2±12.0 years) and 9 for participants with WD (5 women and 4 men, mean age 30.7±8.5 years). There was no significant difference in mean age between participants with PD or WD and normal controls (Table 1) .
I-beta-CIT SPECT Acquisition and Reconstruction
In participants with PD, antiparkinsonian medications were stopped for 48 h prior to image acquisition. All participants I-beta-CIT 370 MBq was performed over 30 s. SPECT studies were performed using a tripleheaded gamma camera (Prism 3000, Picker, USA) equipped with a medium energy collimator. Scans were obtained 18 h after radioactive material injection. Data were acquired with a 20 % symmetric window centered at 159 keV using a 128× 128 matrix (pixel size 4.67×4.67 mm, slice thickness 4.67 mm) and reconstructed by filtered back projection with a Butterworth filter (cutoff 0.4 cycle/cm, order 7). Chang's method of attenuation correction (μ 0.1/cm) was employed.
SPM Analysis SPM99 (statistical parametric mapping, University Collage of London, UK) and Matlab 6.5 (Mathwork Inc., USA) software was used for spatial matching and statistical analysis. We developed a standard anatomical brain template for dopamine receptor and transporter images using SPAM. In this study, as we did not have 3D MRI brain images, we used SPAM to create the standard template using the following sequence (Figs. 1 and 2).
(1) Create whole-head images by binary-coding selected SPM-provided proton density-weighted MR images with pixel values greater than 5,000. (2) Create whole-brain images by summing the gray matter and white matter SPAM templates. (5) Sum the SPAM images of the striatium, brain (whole brain image, WBI), and head (whole head image, WHI) and multiply by the following weight parameters:
(6) Create the initial template after smoothing the summed image with a 12-mm Gaussian kernel to be made equal to the resolution of the SPECT image. (7) Create the final standard template by averaging the SPECT images of ten normal controls that were spatially normalized to the initial template and count-normalized to the cerebellum.
All participants' 123 I-beta-CIT SPECT images were spatially normalized to the standard template using affine and nonlinear transformation and count-normalized to the cerebellum.
Analyses of covariate tests in SPM were performed with age covariation to elucidate differences between participants with PD or WD and normal controls. The error due to multiple comparisons was corrected with the false discovery rate (FDR) regulation method. P-values less than 0.05 were considered to be significant. An accumulated mass of more than 50 contiguous voxels was defined as a significantly different area.
Analysis and Quantification of Binding Potential with SPAM
Spatial-and count-normalized images were subdivided into probabilistic ROIs with the Montreal Neurological Institute (MNI) SPAM template. Each voxel of SPAM has the probability (0 to 1) of belonging to 98 ROIs that comprise the MNI template. The ROI count can be measured as a probability-weighted mean count, defined as the sum of voxel counts multiplied by the voxel probability of the brain ROI. With this quantification method using SPAM, the probabilityweighted mean counts were measured in the caudate head, anterior putamen, posterior putamen, and cerebellum as a nonspecific binding area (Fig. 3) .
The binding potential is defined as the specific-nonspecific uptake ratio at equilibrium. We defined the specific uptake areas as the caudate head, anterior putamen, and posterior putamen. We defined the nonspecific uptake area as the cerebellum. The binding potential (BP) was calculated using the following formula:
BP ¼ ð count per pixel of specific binding areas =count per pixel of nonspecific binding areas Þ À 1 Binding potential measurements were performed twice in all study participants by a single observer using the same method; measurements were compared to test for reproducibility. To compare the reduction in binding potential area between participants with PD and those with WD, the Z-score of each area was calculated as follows: We compared the binding potential between disease groups and controls using the general linear model with age covariation. We used the Bonferroni correction to make multiple binding potential comparisons of the six ROIs (bilateral caudate heads, anterior putamina, and posterior putamina). We used paired ttests to compare Z-scores between groups.
Results
SPM Analysis
Using SPM99 software, we found significant differences between the binding potentials of the disease group's volumetric areas and those of the control groups. In participants with PD, binding potentials were significantly lower than those of normal controls in the bilateral caudate heads, anterior putamina, and posterior putamina ( Table 2 ). This area of decreased binding potential can be represented by the whole striatum (Fig. 4) . Similarly, in participants with WD, binding potentials were also significantly lower than those of normal controls in bilateral caudate heads, anterior putamina, and posterior putamina (Table 3) . Again, this area of decreased binding potential can be represented by the whole striatum (Fig. 5) . When comparing disease groups, the binding potentials of the posterior putamen were significantly decreased in participants with PD compared to those of participants with WD (Fig. 6 ).
Quantification of Binding Potential Using SPAM
Our automated method successfully obtained the binding potentials of the caudate, anterior putamen, and posterior putamen from all study participants (Table 4 ). In participants with PD, the binding potentials of all striatal areas were significantly lower than those of normal controls (Fig. 7) . Similarly, the striatal binding potentials of participants with WD were also significantly lower than those of normal controls (Fig. 8 ).
In participants with PD, the regional Z-score of the binding potential in the caudate was −3.09, significantly different from those of the anterior putamen (−3.57) and posterior putamen (−3.61) (p <0.005). In participants with WD, however, the regional Z-scores of the caudate, anterior putamen, and posterior putamen were −3.00, −3.09, and −3.00, values that are not significantly different from each other (p> 0.690) (Fig. 9 ).
Discussion
Recently, many clinical and experimental trials of dopamine receptor imaging have been performed [8] [9] [10] . In this study, we normalized 123 I-beta-CIT images using SPAM in terms of shape and count and obtained binding potentials using an automated method. It is known that striatal uptake of 123 Ibeta-CIT decreases with age [11] . Given that the mean age of participants in the disease group was significantly different from the mean age of controls, we created age-matched normal control groups for each disease group (PD and WD). In line with previous reports, SPM analysis found that striatal uptake was significantly lower in patients with PD or WD compared to normal controls (Figs. 4-5) [7, 12, 13] .
Although PD and WD cause similar Parkinsonian motor symptoms, there are differences in both the pathophysiology and visual 123 I-beta-CIT SPECT images of patients with the disease [7] . Our SPM analysis showed differences in uptake in the posterior putamen between participants with PD and those with WD (Fig. 6) . Therefore, we measured the individual binding potentials of different striatal regions using VOIs of SPAM.
We used SPAM of the caudate, anterior putamen, posterior putamen, and cerebellum as VOIs. The occipital lobe is also commonly used as a non-specific uptake region of reference in such studies. In this study, however, we used the cerebellum as the region of reference because we found that individual variations in occipital uptake were higher than variations in cerebellar uptake.
In this study, we found that the binding potentials of all striatal regions (caudate, anterior putamen, posterior putamen) in participants with PD or WD were significantly lower than those of normal controls. In a Z-score comparison, the binding potentials of the putamen in participants with PD were more significantly decreased than those of the caudate. This difference between Z-scores of the caudate and putamen was negligible in participants with WD. This result suggests that posterior striatum (putamen) involvement preceded the involvement of other striatal regions in PD [14] .
In WD, the reductions in binding potential were not significantly different in the caudate, anterior putamen, or posterior putamen. In contrast, a previous study found significant differences in binding potential reduction between the caudate and putamen [12] . This discrepancy may be due to the small number of participants in our study. Many tracers used in dopamine receptor imaging have high specificity, leading to visual estimation as the mainstream method of analysis. However, it is very difficult to visually separate the caudate from the putamen in 123 I-beta-CIT SPECT images, leading instead to visual estimation of the binding potential of the whole striatum. Furthermore, visual estimation of subtle differences in uptake lead to wide variation in reference regions [7, 15] . A standard brain template may reduce these variations. The first trials of SPM and SPAM for dopamine receptor imaging began in PET scans [16] . Standard brain templates based on MRI can provide high-resolution images and objective structural differentiation. In our study, each subject image was normalized by structural matching, and their binding potentials were obtained using a template derived from standard MNI SPAM. This method reduced observer error and yielded superb reproducibility.
In a recently published study about automated analysis for dopamine receptor imaging, suboptimal VOI positioning occurred in nearly half the cases [17] . In contrast, our use of SPM with the MNI SPAM template may have resulted in proper structural normalization.
In conclusion, automated analysis of 123 I-beta-CIT SPECT images using SPM and SPAM was successful for participants with PD, WD, and normal controls. Our methods found significantly decreased striatal binding potential in both WD and PD compared to normal controls. We further elucidated differences in regional binding potential between PD and WD by obtaining the regional binding potential of each subject. Using this automated method, we achieved an accurate and objective quantitative analysis of dopamine receptor images. 
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